Boonyasiri Adhiratha, Thaisiam Peerapat, Permpikul Chairat, Judaeng Tepnimitr, Suiwongsa Bordeesuda, Apiradeewajeset Napaporn, Fakthongphan Teerawan, Suddee Sunun, Laoagtipparos Wandee, Thamlikitkul Visanu
Faculty of Medicine Siriraj Hospital,Mahidol University,Bangkok,Thailand.
Infect Control Hosp Epidemiol. 2016 Mar;37(3):245-53. doi: 10.1017/ice.2015.285.
To determine the effectiveness of daily bathing with 2% chlorhexidine-impregnated washcloths in preventing multidrug-resistant (MDR) gram-positive bacterial colonization and bloodstream infection.
A randomized, open-label controlled trial was conducted in 4 medical intensive care units (ICUs) in Thailand from December 2013 to January 2015. Patients were randomized to receive cleansing with non-antimicrobial soap (control group) or 2% chlorhexidine-impregnated washcloths used to wipe the patient's body once daily (chlorhexidine group). Swabs were taken from nares, axilla, antecubital, groin, and perianal areas on admission and on day 3, 5, 7, and 14. The 5 outcomes were (1) favorable events ( all samples negative throughout ICU admission, or initially positive samples with subsequent negative samples); (2) MDR bacteria colonization-free time; (3) hospital-acquired infection; (4) length of ICU and hospital stay; (5) adverse skin reactions.
A total of 481 patients were randomly assigned to the control group (241) or the chlorhexidine group (240). Favorable events at day 14 were observed in 34.8% of patients in the control group and 28.6% in the chlorhexidine group (P=.79). Median MDR bacteria colonization-free times were 5 days in both groups. The incidence rate of hospital-acquired infection and the length of the ICU and hospital stay did not differ significantly between groups. The incidence of adverse skin reactions in the chlorhexidine group was 2.5%.
The effectiveness of 2% chlorhexidine-impregnated washcloths for the prevention of MDR gram-negative bacteria colonization and hospital-acquired infection in adult patients in ICU was not proven. TRIAL REGISTRATION ClinicalTrials.gov identifier: NCT01989416.
确定使用含2%氯己定的浴巾每日进行沐浴在预防多重耐药(MDR)革兰氏阳性菌定植和血流感染方面的有效性。
2013年12月至2015年1月在泰国的4个医学重症监护病房(ICU)进行了一项随机、开放标签对照试验。患者被随机分为接受使用非抗菌肥皂清洁(对照组)或使用含2%氯己定的浴巾每日擦拭患者身体一次(氯己定组)。在入院时以及第3、5、7和14天从鼻孔、腋窝、肘前、腹股沟和肛周区域采集拭子。5项观察指标为:(1)良好事件(在整个ICU住院期间所有样本均为阴性,或初始样本为阳性但随后样本为阴性);(2)无MDR细菌定植时间;(3)医院获得性感染;(4)ICU住院时间和医院住院时间;(5)皮肤不良反应。
共有481例患者被随机分配至对照组(241例)或氯己定组(240例)。对照组14天时观察到良好事件的患者比例为34.8%,氯己定组为28.6%(P = 0.79)。两组的MDR细菌无定植时间中位数均为5天。两组之间医院获得性感染的发生率以及ICU住院时间和医院住院时间并无显著差异。氯己定组皮肤不良反应的发生率为2.5%。
含2%氯己定的浴巾预防ICU成年患者MDR革兰氏阴性菌定植和医院获得性感染的有效性未得到证实。试验注册ClinicalTrials.gov标识符:NCT01989416。